← Leaderboards
Jeffrey A Bluestone
University Of Chicago
$76,504,040
Attributed
$86,577,490
Total exposure
34
Grants
13
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $41.7M · FY2005–20$50M$37.5M$25M$12.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$88,505,408 · 36
By mechanism
N01$54,160,400 · 3
U01$10,877,402 · 3
P01$5,759,245 · 6
R01$5,670,357 · 3
P30$3,572,457 · 12
UC4$3,351,746 · 1
Top collaborators
- Sandy Feng7 shared
- Matthias Hebrok7 shared
- Sang-Mo Kang7 shared
- Qizhi Tang7 shared
- Mark S Anderson4 shared
- Michael S German3 shared
- Feroz R Papa3 shared
- Didier Y Stainier3 shared
Most similar at University Of Chicago
Same institution · by research overlap
- Leslie J De Groot$2,330,854
- Lee Ann Garrett-Sinha$3,749,557
Others in their field
Top investigators on “Base”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$613,567,095
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Larry Arthur$521,411,998
- Leonard Freedman · Leidos Biomedical Research, Inc.$515,995,429
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$507,042,060
Research focus
BaseT-LymphocyteCellsIn VivoAutoimmunityIn VitroIsletImmune SystemRegulatory T-LymphocyteImmune ResponseAutoantigensAntigensAutoimmune DiseasesTissuesAutoimmune ProcessMouse ModelPreventCytokineResearch PersonnelDiabetes MellitusRegulationLeadImmuneImmunoregulation
Grant awards (112)
Project 2 - Specificity and repertoire of Tregs in T1D$382,872
P01 · FY2020 · AI · contact PI
Using human stem cell-derived thymic epithelium to remodel T1D immune tolerance$578,390
U01 · FY2019 · DK
Project 2 - Specificity and repertoire of Tregs in T1D$385,432
P01 · FY2019 · AI · contact PI
Donor-Alloantigen-Reactive Regulatory T Cell Therapy in Liver Transplantation$845,402
U01 · FY2018 · AI
Using human stem cell-derived thymic epithelium to remodel T1D immune tolerance$578,390
U01 · FY2018 · DK
Project 2 - Specificity and repertoire of Tregs in T1D$390,222
P01 · FY2018 · AI · contact PI
Designer Tregs for restoring tolerance in patients with type 1 diabetes$3,351,746
UC4 · FY2017 · DK · contact PI
Donor-Alloantigen-Reactive Regulatory T Cell Therapy in Liver Transplantation$987,163
U01 · FY2017 · AI
Using human stem cell-derived thymic epithelium to remodel T1D immune tolerance$578,390
U01 · FY2017 · DK
Project 2 - Specificity and repertoire of Tregs in T1D$384,989
P01 · FY2017 · AI · contact PI
Donor-Alloantigen-Reactive Regulatory T Cell Therapy in Liver Transplantation$976,841
U01 · FY2016 · AI
Using human stem cell-derived thymic epithelium to remodel T1D immune tolerance$578,390
U01 · FY2016 · DK
Project 2 - Specificity and repertoire of Tregs in T1D$408,722
P01 · FY2016 · AI · contact PI
Donor-Alloantigen-Reactive Regulatory T Cell Therapy in Liver Transplantation$982,619
U01 · FY2015 · AI
Immunomodulation of transplant rejection by Anti-CD3 mAb$347,625
R01 · FY2015 · AI · contact PI
Role of Innate Lymphoid Cells in Autoimmunity$197,761
R21 · FY2015 · AI · contact PI
Donor-Alloantigen-Reactive Regulatory T Cell Therapy in Liver Transplantation$983,209
U01 · FY2014 · AI
Immunomodulation of transplant rejection by Anti-CD3 mAb$347,625
R01 · FY2014 · AI · contact PI
Role of Innate Lymphoid Cells in Autoimmunity$236,125
R21 · FY2014 · AI · contact PI
Immunomodulation of transplant rejection by Anti-CD3 mAb$326,768
R01 · FY2013 · AI · contact PI
Genetically Engineered Antigen Specific Treg to Treat Autoimmunity$178,076
U19 · FY2013 · AI · contact PI
"Donor-Specific Regulatory T Cell Therapy in Liver Transplantation"$57,242
R34 · FY2013 · AI
"Expanding beta-cell mass"$1,301,497
U01 · FY2012 · DK
Immunomodulation of transplant rejection by Anti-CD3 mAb$347,625
R01 · FY2012 · AI · contact PI
"Donor-Specific Regulatory T Cell Therapy in Liver Transplantation"$246,373
R34 · FY2012 · AI
Genetically Engineered Antigen Specific Treg to Treat Autoimmunity$196,503
U19 · FY2012 · AI · contact PI
"Expanding beta-cell mass"$1,301,500
U01 · FY2011 · DK
Immunomodulation of transplant rejection by Anti-CD3 mAb$347,625
R01 · FY2011 · AI · contact PI
Spontaneous Autoimmune Model of Peripheral Neuropathy$334,234
R01 · FY2011 · AI · contact PI
Genetically Engineered Antigen Specific Treg to Treat Autoimmunity$197,234
U19 · FY2011 · AI · contact PI
"Expanding beta-cell mass"$1,185,611
U01 · FY2010 · DK
Spontaneous Autoimmune Model of Peripheral Neuropathy$337,610
R01 · FY2010 · AI · contact PI
CTLA-4 functions in tolerance and autoimmunity$322,094
P01 · FY2010 · AI · contact PI
Flow Cytometry$231,347
P01 · FY2010 · AI · contact PI
Islet Metabolism Core$212,634
P30 · FY2010 · DK · contact PI
Genetically Engineered Antigen Specific Treg to Treat Autoimmunity$201,140
U19 · FY2010 · AI · contact PI
Spontaneous Autoimmune Model of Peripheral Neuropathy$42,390
R01 · FY2010 · AI · contact PI
Immune Tolerance Network: Type 1 diabetes$4,435,333
N01 · FY2009 · AI · contact PI
Immune Tolerance Network: Kidney, Liver and Bone Marrow Transplantation$2,919,368
N01 · FY2009 · AI · contact PI
Immune Tolerance Network: Food Allergy$2,071,809
N01 · FY2009 · AI · contact PI
Immune tolerance network: liver transplantation$1,412,597
N01 · FY2009 · AI · contact PI
Immune tolerance network: Autoimmune diseases: Vasculitis$1,130,077
N01 · FY2009 · AI · contact PI
Immune tolerance network: Multiple sclerosis$941,730
N01 · FY2009 · AI · contact PI
Spontaneous Autoimmune Model of Peripheral Neuropathy$341,020
R01 · FY2009 · AI · contact PI
CTLA-4 functions in tolerance and autoimmunity$316,784
P01 · FY2009 · AI · contact PI
IMMUNOMODULATION OF TRANSPLANT REJECTION BY ANTI-CD3 MAB$281,840
R37 · FY2009 · AI · contact PI
Flow Cytometry$227,347
P01 · FY2009 · AI · contact PI
Genetically Engineered Antigen Specific Treg to Treat Autoimmunity$197,396
U19 · FY2009 · AI · contact PI
Immune Tolerance Network: Systemic lupus rythematosus (SLE)$188,346
N01 · FY2009 · AI · contact PI
Immune tolerance network: Islet cell transplantation$188,346
N01 · FY2009 · AI · contact PI
Immune tolerance network: lung transplantation$94,175
N01 · FY2009 · AI · contact PI
Immune tolerance network: heart tranplantation$94,175
N01 · FY2009 · AI · contact PI
Immune tolerance network: Rheumatoid arthritis$94,173
N01 · FY2009 · AI · contact PI
Spontaneous Autoimmune Model of Peripheral Neuropathy$340,928
R01 · FY2008 · AI · contact PI
CTLA-4 functions in tolerance and autoimmunity$308,480
P01 · FY2008 · AI · contact PI
IMMUNOMODULATION OF TRANSPLANT REJECTION BY ANTI-CD3 MAB$281,840
R37 · FY2008 · AI · contact PI
Flow Cytometry$221,183
P01 · FY2008 · AI · contact PI
IMMUNE TOLERANCE NETWORK$40,350,271
N01 · FY2007 · AI · contact PI
Spontaneous Autoimmune Model of Peripheral Neuropathy$346,406
R01 · FY2007 · AI · contact PI
CTLA-4 functions in tolerance and autoimmunity$297,601
P01 · FY2007 · AI · contact PI
IMMUNOMODULATION OF TRANSPLANT REJECTION BY ANTI-CD3 MAB$287,299
R37 · FY2007 · AI · contact PI
Flow Cytometry$241,232
P01 · FY2007 · AI · contact PI
Islet Core$209,691
P30 · FY2007 · DK · contact PI
CTLA-4 functions in tolerance and autoimmunity$296,947
P01 · FY2006 · AI · contact PI
IMMUNOMODULATION OF TRANSPLANT REJECTION BY ANTI-CD3 MAB$295,880
R37 · FY2006 · AI · contact PI
Spontaneous Autoimmune Model of Peripheral Neuropathy$258,895
R01 · FY2006 · AI · contact PI
Flow Cytometry$240,471
P01 · FY2006 · AI · contact PI
IMMUNE TOLERANCE NETWORK-266015416-266015416$0
N01 · FY2006 · AI · contact PI
IMMUNOMODULATION OF TRANSPLANT REJECTION BY ANTI-CD3 MAB$303,000
R37 · FY2005 · AI
Spontaneous Autoimmune Model of Peripheral Neuropathy$265,125
R01 · FY2005 · AI
Role of Notch 1 in Immune Tolerance$227,250
R21 · FY2005 · AI
Spontaneous Autoimmune Model of Peripheral Neuropathy$265,125
R01 · FY2004 · AI
IMMUNOMODULATION OF TRANSPLANT REJECTION BY ANTI-CD3 MAB$249,729
R37 · FY2004 · AI
Role of Notch 1 in Immune Tolerance$227,250
R21 · FY2004 · AI
Diabetes Research and Training Center$1,178,346
P30 · FY2003 · DK
Spontaneous Autoimmune Model of Peripheral Neuropathy$263,446
R01 · FY2003 · AI
CORE--GENOMICS AND BIOINFORMATICS$242,245
P30 · FY2003 · DK
IMMUNOMODULATION OF TRANSPLANT REJECTION BY ANTI-CD3 MAB$242,069
R37 · FY2003 · AI
CORE--MOUSE GENETICS$238,386
P30 · FY2003 · DK
CORE--ISLET PRODUCTION$222,510
P30 · FY2003 · DK
ADMINISTRATIVE CORE$192,967
P30 · FY2003 · DK
CORE--MICROSOPY AND CELLULAR IMAGING$130,822
P30 · FY2003 · DK
PILOT AND FEASIBILITY PROGRAM$75,708
P30 · FY2003 · DK
Pilot and Feasibility$0
P30 · FY2003 · DK
Spontaneous Autoimmune Model of Peripheral Neuropathy$289,325
R01 · FY2002 · AI
IMMUNOMODULATION OF TRANSPLANT REJECTION BY ANTI-CD3 MAB$235,947
R37 · FY2002 · AI
Conf on Mechanism and Applications of Immune Tolerance$13,000
R13 · FY2002 · AI
CTLA-4-based tolerance in autoimmune diabetes$0
P01 · FY2002 · AI
Core--Flow Cytometry$0
P01 · FY2002 · AI
TOLERANCE OF ISLET CELL GRAFT$325,869
R01 · FY2001 · DK
IMMUNOMODULATION OF TRANSPLANT REJECTION BY ANTI-CD3 MAB$228,534
R37 · FY2001 · AI
IMMUNOLOGY AND CANCER$0
P30 · FY2001 · CA
CORE--FLOW CYTOMETRY AND IMMUNOHISTOCHEMISTRY FACILITY$0
P30 · FY2001 · CA
CORE--FLOW CYTOMETRY AND IMMUNOHISTOCHEMISTRY FACILITY$0
P30 · FY2001 · CA
CORE--ANIMAL BARRIER FACILITY$0
P30 · FY2001 · CA
CORE--ANIMAL BARRIER FACILITY$0
P30 · FY2001 · CA
IMMUNOLOGY AND CANCER$0
P30 · FY2001 · CA
Core--Flow Cytometry$0
P01 · FY2001 · AI
CTLA-4-based tolerance in autoimmune diabetes$0
P01 · FY2001 · AI
COSTIMULATION IN PERIPHERAL T CELL TOLERANCE AND ANERGY$749,572
P01 · FY2000 · AI
TOLERANCE OF ISLET CELL GRAFT$448,306
R01 · FY2000 · DK
MOFLO MULTILASER FLOW CYTOMETER$399,462
S10 · FY2000 · RR
CORE--ANIMAL BARRIER FACILITY$289,716
P30 · FY2000 · CA
CORE--FLOW CYTOMETRY AND IMMUNOHISTOCHEMISTRY FACILITY$289,716
P30 · FY2000 · CA
IMMUNOLOGY AND CANCER$289,716
P30 · FY2000 · CA
COLLABORATIVE NETWORK FOR CLINICAL RES ON IMMUNE TOLERAN$240,000
N01 · FY2000 · AI
IN VIVO MODELS OF PERIPHERAL TOLERANCE AND ANERGY$176,975
P01 · FY2000 · AI
CORE--ANIMAL FACILITY$176,975
P01 · FY2000 · AI
IMMUNOMODULATION OF TRANSPLANT REJECTION BY ANTI-CD3 MAB$124,851
R37 · FY2000 · AI
IMMUNOMODULATION OF TRANSPLANT REJECTION BY ANTI-CD3 MAB$87,048
R01 · FY2000 · AI
FASEB SUMMER CONFERENCE--LYMPHOCYTES AND ANTIBODIES$8,000
R13 · FY2000 · AI
TOLERANCE OF ISLET CELL GRAFT$7,362
R01 · FY2000 · DK